These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 30260706)
21. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis. Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267 [TBL] [Abstract][Full Text] [Related]
22. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Geng J; Yang C; Wang B; Zhang X; Hu T; Gu Y; Li J Biomed Pharmacother; 2018 Jan; 97():941-947. PubMed ID: 29136772 [TBL] [Abstract][Full Text] [Related]
23. The effect of oxidized low-density lipoprotein (ox-LDL) on radiation-induced endothelial-to-mesenchymal transition. Kim M; Choi SH; Jin YB; Lee HJ; Ji YH; Kim J; Lee YS; Lee YJ Int J Radiat Biol; 2013 May; 89(5):356-63. PubMed ID: 23289363 [TBL] [Abstract][Full Text] [Related]
24. Pyrogallol-Phloroglucinol-6 6-Bieckol on Attenuates High-Fat Diet-Induced Hypertension by Modulating Endothelial-to-Mesenchymal Transition in the Aorta of Mice. Son M; Oh S; Jang JT; Son KH; Byun K Oxid Med Cell Longev; 2021; 2021():8869085. PubMed ID: 33574986 [TBL] [Abstract][Full Text] [Related]
25. Neutrophil extracellular traps modulate inflammatory markers and uptake of oxidized LDL by human and murine macrophages. Conforti A; Wahlers T; Paunel-Görgülü A PLoS One; 2021; 16(11):e0259894. PubMed ID: 34797846 [TBL] [Abstract][Full Text] [Related]
26. Endothelial extracellular vesicles modulate the macrophage phenotype: Potential implications in atherosclerosis. He S; Wu C; Xiao J; Li D; Sun Z; Li M Scand J Immunol; 2018 Apr; 87(4):e12648. PubMed ID: 29465752 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice. Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139 [TBL] [Abstract][Full Text] [Related]
28. Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II. Wang Z; Wei Q; Han L; Cao K; Lan T; Xu Z; Wang Y; Gao Y; Xue J; Shan F; Feng J; Xie X J Cell Mol Med; 2018 Jan; 22(1):429-438. PubMed ID: 28857429 [TBL] [Abstract][Full Text] [Related]
29. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability. Tang H; Zhu M; Zhao G; Fu W; Shi Z; Ding Y; Tang X; Guo D Atherosclerosis; 2018 Aug; 275():58-67. PubMed ID: 29860109 [TBL] [Abstract][Full Text] [Related]
33. Oxidized LDL activated eosinophil polarize macrophage phenotype from M2 to M1 through activation of CD36 scavenger receptor. Qin M; Wang L; Li F; Yang M; Song L; Tian F; Yukht A; Shah PK; Rothenberg ME; Sharifi BG Atherosclerosis; 2017 Aug; 263():82-91. PubMed ID: 28623741 [TBL] [Abstract][Full Text] [Related]
34. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice. Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554 [TBL] [Abstract][Full Text] [Related]
35. The interleukin-1 receptor type-1 in disturbed flow-induced endothelial mesenchymal activation. Kidder E; Pea M; Cheng S; Koppada SP; Visvanathan S; Henderson Q; Thuzar M; Yu X; Alfaidi M Front Cardiovasc Med; 2023; 10():1190460. PubMed ID: 37539090 [TBL] [Abstract][Full Text] [Related]
36. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist. Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243 [TBL] [Abstract][Full Text] [Related]
37. Endothelial-mesenchymal transition in atherosclerotic lesion calcification. Boström KI; Yao J; Guihard PJ; Blazquez-Medela AM; Yao Y Atherosclerosis; 2016 Oct; 253():124-127. PubMed ID: 27615595 [TBL] [Abstract][Full Text] [Related]
38. TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing. Ma J; van der Zon G; Sanchez-Duffhues G; Ten Dijke P J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720132 [TBL] [Abstract][Full Text] [Related]
39. Tenascin-X Mediates Flow-Induced Suppression of EndMT and Atherosclerosis. Liang G; Wang S; Shao J; Jin YJ; Xu L; Yan Y; Günther S; Wang L; Offermanns S Circ Res; 2022 May; 130(11):1647-1659. PubMed ID: 35443807 [TBL] [Abstract][Full Text] [Related]
40. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques. Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]